ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Back pain"

  • Abstract Number: 1973 • ACR Convergence 2023

    Work-related Impact in Young Patients with Chronic Back Pain Awaiting a Magnetic Resonance Imaging

    Diego Benavent1, Mar Tapia2, Daniel Bernabeu2, Victor muley2, Chamaida Plasencia-Rodríguez3, Alejandro Balsa3 and Victoria Navarro-Compán4, 1Hospital la Paz, Madrid, Spain, 2Radiology Department, Hospital La Paz, Madrid, Spain, 3Hospital Universitario La Paz, Madrid, Spain, 4Department of Rheumatology, La Paz University Hospital, IdiPaz, Madrid, Spain

    Background/Purpose: Chronic back pain (CBP) is one of the major causes for medical consultation among young people. Given the limited sources, it is relevant knowing…
  • Abstract Number: 0833 • ACR Convergence 2022

    Disability Among Persons with Chronic Severe Back Pain: Results from a Nationally Representative Population Based Sample

    Debbie Feldman1 and Richard Nahin2, 1University of Montreal, Montréal, QC, Canada, 2NIH, Bethesda, MD

    Background/Purpose: With the high prevalence of back pain and the high costs associated with the cases that become chronic there has been an emphasis on…
  • Abstract Number: 0834 • ACR Convergence 2022

    Use of the Routine Assessment of Patient Index Data 3 (RAPID3) Questionnaire in the Assessment of Chronic Lower Back Pain

    Brendan Thoms1, Bradley Tompkins2 and Chi Chi Lau1, 1University of Vermont Medical Center, Burlington, VT, 2University of Vermont, Burlington, VT

    Background/Purpose: Chronic lower back pain (LBP) is a common primary care presentation with substantial socio-economic impact. There are several indices to measure pain / function…
  • Abstract Number: 1942 • ACR Convergence 2022

    Maybe Silent: Spine Disease in Chronic Recurrent Multifocal Osteomyelitis, Clinical Features, Risk Factors, and Red Flags

    Shima Yasin1, T. Shawn Sato2, Emma Leisinger2, Aleksander Lenert2, Yongdong (Dan) Zhao3 and Polly Ferguson1, 1University of Iowa Carver College of Medicine, Iowa City, IA, 2University of Iowa, Iowa City, IA, 3University of Washington, Redmond, WA

    Background/Purpose: Chronic recurrent multifocal osteomyelitis (CRMO) is a female predominant autoinflammatory bone disease. The average age at disease onset is 9-10 years. The majority have…
  • Abstract Number: PP25 • ACR Convergence 2022

    From Denial of Spondyloarthritis to Becoming a Support Group Leader and Medical Doctor of Rheumatology: A Patient’s Perspective

    Shung Chiu1 and Mei Nee Chiu2, 1Spondylitis Association of America, Ludhiana, Punjab, India, 2University Institute of Pharmaceutical Sciences, Panjab University, Ludhiana, Punjab, India

    Background/Purpose: From being a table tennis champion to getting into medical school, I thought my life was smooth sailing. But little did I know it…
  • Abstract Number: 0057 • ACR Convergence 2022

    Accelerating AxSpA Diagnosis: Exploring At-home Self-sampling, Symptom Checkers, Medical Student-visits and Asynchronous Report-based Assessment

    Hannah Labinsky1, Sophie von Rohr2, Maria Gabriella Raimondo3, Ekaterina Vogt4, Britta Horstmann2, Isabel Gehring5, Jessica Rojas-Restrepo5, Fabian Proft6, Felix Mühlensiepen7, Daniela Bohr2, Georg Schett8, Andreas Ramming3 and Johannes Knitza3, 1Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, 91054 Erlangen, Germany; Deutsches Zentrum Immuntherapie, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany, 2Department of Internal Medicine 3, Rheumatology & Immunology, Friedrich-Alexander-University (FAU) Erlangen-Nurnberg and University Hospital Erlangen, Erlangen, Germany, 3Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, 91054 Erlangen, Germany; Deutsches Zentrum Immuntherapie, Friedrich-Alexander-UniversityErlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany, 4Thermo Fisher Scientific, Freiburg, Germany, 5Thermo Fisher Scientific, Freiburg, 6Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité – Universitätsmedizin Berlin, Berlin, Germany, 7Center for Health Services Research, Brandenburg Medical School Theodor Fontane, Rüdersdorf, 8Universitätsklinikum Erlangen, Erlangen, Germany

    Background/Purpose: The growing shortage of rheumatologists threatens adequate rheumatological care. The diagnostic delay for axial spondyloarthritis (axSpA) is particularly long, ranging between 3 to 11…
  • Abstract Number: 0374 • ACR Convergence 2022

    The BASDAI Index During Pregnancy

    Olga Krichevskaya, Tatiana Dubinina, Ekaterina Ilinih, Svetlana Glukhova, Anastasia Demina and Irina Andrianova, V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia

    Background/Purpose: During pregnancy, BASDAI may reflect not only the activity of ankylosing spondylitis (AS), but also back pain and fatigue, that are associated with the…
  • Abstract Number: 0420 • ACR Convergence 2022

    What Does It Mean – A Good Response to NSAIDs? A Systematic Comparison of Patients with Axial Spondyloarthritis and Controls with Chronic Back Pain

    Xenofon Baraliakos1, Imke Redeker2, Elena Bergmann3, Styliani Tsiami4 and Juergen Braun5, 1Rheumazentrum Ruhrgebiet Herne, Herne, Germany, 2Rheumazentrum Ruhrgebiet Herne, Ruhr University Bochum, Bochum, Germany, 3Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany, 4Rheumazentrum Ruhrgebiet, Herne, Ruhr-University Bochum, Herne, Germany, 5Rheumazentrum Ruhrgebiet, Herne, Germany

    Background/Purpose: A fast response to NSAIDs is an important finding in the evaluation of clinical findings within the items comprising the ASAS classification criteria but…
  • Abstract Number: 0370 • ACR Convergence 2021

    Awareness and Attitudes Regarding Axial Spondyloarthritis Among Primary Care Providers

    Yuliya Afinogenova1, Swetha Ann Alexander2, Narinder Maheshwari3, Sonam Kiwalkar4 and Abhijeet Danve5, 1Yale School of Medicine, Hamden, CT, 2University of Connecticut, Hartford, CT, 3UConn Health, West Hartford, CT, 4The Vancouver Clinic, Portland, OR, 5Yale University, Rocky Hill, CT

    Background/Purpose: There is significant discrepancy between population and diagnostic prevalence of axial spondyloarthritis (axSpA) and ankylosing spondylitis (AS) in the US. Delayed and missed diagnosis…
  • Abstract Number: 0371 • ACR Convergence 2021

    Self-referral Strategy for Early Diagnosis of Axial Spondyloarthritis- Preliminary Analysis from Finding Axial Spondyloarthritis Study

    Yuliya Afinogenova1, Swetha Ann Alexander2, Andrew Haims3 and Abhijeet Danve4, 1Yale School of Medicine, Hamden, CT, 2University of Connecticut, Hartford, CT, 3Yale School of Medicine, New Haven, CT, 4Yale University, Rocky Hill, CT

    Background/Purpose: Lack of timely rheumatology referral for suspected axial spondyloarthritis (axSpA) is a major contributor to delayed diagnosis in patients with chronic back pain (CBP).…
  • Abstract Number: 0377 • ACR Convergence 2021

    The Prevalence of Inflammatory Back Pain and HLA-B27 in a Large Population-Based Cohort in the Netherlands

    Stan Kieskamp, Suzanne Arends, Elisabeth Brouwer, Hendrika Bootsma, Ilja Nolte and Anneke Spoorenberg, University Medical Center Groningen, Groningen, Netherlands

    Background/Purpose: Chronic low back pain (CLBP; back pain >3 months) with onset at age < 45 and inflammatory back pain (IBP) are regarded as early…
  • Abstract Number: 0383 • ACR Convergence 2021

    Differences Between Male vs. Female Presenting with Back Pain in an Integrated Delivery System

    Aniket Kawatkar1, Esther Yi2, Erika Estrada1, Jose Pio1, Cecilia Portugal1, David Yi1 and Steve Lee3, 1Kaiser Permanente Southern California, Pasadena, CA, 2Novartis Pharmaceuticals Corporation, Weehawken, NJ, 3Southern California Permanente Medical Group, Fontana, CA

    Background/Purpose: Back pain exerts significant economic burden and in its inflammatory form is the main clinical symptom of axial spondylarthritis. We evaluated differences in patient…
  • Abstract Number: 0567 • ACR Convergence 2021

    Determinants of Health-Related Quality of Life in Spondyloarthritis and Comparison with Chronic Low Back Pain – Results from a Nation-Wide Study

    Helena Santos1, Ana Rita Henriques2, Ana Maria Rodrigues3, Jaime Branco3 and Helena Canhao3, 1Portuguese Institute of Rheumatology, Lisbon, Portugal, 2EpiDoC Unit, Comprehensive Health Research Centre (CHRC), Lisbon, Portugal, 3EpiDoC Unit, CEDOC, NOVA Medical School, Comprehensive Health Research Centre (CHRC), Lisbon, Portugal

    Background/Purpose: Spondyloarthritis (SpA) causes pain, fatigue, stiffness, loss of physical function and impaired health-related quality of life (HRQoL).This study aims to: 1) to compare HRQoL…
  • Abstract Number: 0919 • ACR Convergence 2021

    Ixekizumab Shows a Distinct Pattern of Pain Improvement Beyond Measurable Inflammation as Assessed by MRI or CRP or BASDAI Questions 5 & 6 in Patients with Ankylosing Spondylitis

    Kurt de Vlam1, Philip Conaghan2, Philip Mease3, Proton Rahman4, Venkatesh Krishnan5, Rebecca Bolce5, David Sandoval Calderon5, So Young Park5, Gaia Gallo5 and Walter Maksymowych6, 1University Hospitals Leuven, Leuven, Belgium, 2Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 3Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle, WA, 4Department of Medicine, Eastern Health and Memorial University of Newfoundland, St John's, NL, Canada, 5Eli Lilly and Company, Indianapolis, IN, 6Department of Medicine, Division of Rheumatology at the University of Alberta, Alberta, Canada

    Background/Purpose: Ixekizumab (IXE) demonstrated rapid efficacy in patients (pts) with AS at week (W) 16 in the absence of elevated inflammation as measured by baseline…
  • Abstract Number: 1024 • ACR Convergence 2021

    Medical Care Seeking Is Frequent and Associated with Overuse of Low-Value Care for Low Back Pain in Portugal: Results from a Nationwide Population-Based Study

    Luís Antunes Gomes1, Eduardo Brazete Cruz2, Ana Rita Henriques1, Jaime Branco3, Helena Canhão4 and Ana Maria Rodrigues3, 1EpiDoC Unit, Comprehensive Health Research Centre (CHRC), Lisbon, Portugal, 2Comprehensive Health Research Centre (CHRC), Setubal, Portugal, 3EpiDoC Unit, CEDOC, Nova Medical School, Comprehensive Health Research Centre (CHRC), Lisbon, Portugal, 4EpiDoC Unit, Comprehensive Health Research Centre (CHRC), Lisboa, Portugal

    Background/Purpose: Low back pain (LBP) constitutes an important cause of disability and morbidity in general population. Appropriate care for LBP includes non-pharmacological interventions based on…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 7
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology